Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,581 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Efficiency and Toxicity Of Anlotinib in Combination With Docetaxel Followed by Epirubicin and Cyclophosphamide Regimen as Neoadjuvant Treatment in IIB to IIIA Triple Negative Breast Cancer: A Single-Arm, Multicenter, Open-Label, Phase II Study.
Chen X, Wei X, Yao P, Liu Y, Guan H, Kang H, Liu D, Diao Y, Ma X, Min W, Shan C, Zhao Y, Zhao F, Chen Y, Xiao D, She Q, Liu Y, Zhang Y, Zhang S. Chen X, et al. Among authors: zhao y, zhao f. Clin Breast Cancer. 2024 Jun;24(4):e195-e202. doi: 10.1016/j.clbc.2024.01.018. Epub 2024 Mar 8. Clin Breast Cancer. 2024. PMID: 38670862 Clinical Trial.
11,581 results
You have reached the last available page of results. Please see the User Guide for more information.